UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC  20549

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): November 2, 2006

 

 

BIOMET, INC.

(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

 

 

 

56 East Bell Drive

Warsaw, Indiana 46582

(Address of Principal Executive Offices, including  Zip Code)

 

 

(574) 267-6639

(Registrant’s Telephone Number, Including Area Code)

 

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o  Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o  Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Item 8.01  Other Events.

This Form 8-K is being filed to provide the information set forth in Biomet, Inc.’s November 2, 2006 press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

The press release contains certain statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. Although Biomet believes that the assumptions, on which the forward-looking statements contained in the press release are based, are reasonable, any of those assumptions could prove to be inaccurate given the inherent uncertainties as to the occurrence or non-occurrence of future events. There can be no assurance that the forward-looking statements contained in the press release will prove to be accurate. The inclusion of a forward-looking statement in the press release should not be regarded as a representation by Biomet that Biomet’s objectives will be achieved.

Item 9.01 Financial Statement and Exhibits.

(d) Exhibits.

Exhibit 99.1   Press Release issued November 2, 2006

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	BIOMET, INC.
	/s/ Gregory D. Hartman
	By:	Gregory D. Hartman
	Its:	Senior Vice President - Finance
		(Principal Financial Officer)

 

Date: November 2, 2006

2